Business Wire

EUNETWORKS

6.12.2022 09:46:41 CET | Business Wire | Press release

Share
euNetworks Board Agrees to the Appointment of Paula Cogan as Chief Executive Officer as Brady Rafuse Will Become Chairman of euNetworks’ Board of Directors

euNetworks Group Limited (“euNetworks”), a Western European bandwidth infrastructure company, today announced that its Board of Directors has agreed to the appointment of Paula Cogan as its Chief Executive Officer, effective 1 January 2023. Paula currently holds the position of President, euNetworks. Paula will succeed CEO Brady Rafuse, who will become Chairman of euNetworks’ Board of Directors, with the existing Chairman Neil Hobbs remaining on the Board of Directors as a Non Executive Director.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221206005159/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Paula Cogan, euNetworks (Photo: Business Wire)

Paula is currently President, euNetworks, with responsibility for all operating aspects of the business. She joined euNetworks in November 2021, building on her 30 years of working in the telecoms industry. She has held various senior leadership positions in companies such as British Telecom, Verizon and Colt. Prior to joining euNetworks Paula was most recently Executive Vice President – Sales, Marketing and Customer Relationship Management at Colt, responsible for the commercial strategy of the business. Throughout her career Paula has been known for driving transformation in both teams and organisations, leading global sales, marketing, engineering and commercial teams as well as building successful channel strategies. With a strong track record in people management and mentoring, she is committed to promoting and driving inclusion and diversity within the telecoms Industry.

“I am excited to lead this exceptional and high-performing team of people through the next chapter of euNetworks’ growth,” said Paula Cogan. “euNetworks continues to distinguish itself in the digital infrastructure ecosystem, delivering critical internet infrastructure to customers. It’s an asset rich business, focused on developing and deepening its fibre networks, innovating and investing in new technologies to deliver highly scalable, owned and operated fibre-based and sustainable infrastructure in Europe. The vision that Brady and the team have followed and delivered creates an exciting opportunity for us all as we continue to drive the business forward. I want to thank Brady for that and also for his continued support as Chairman as we move forward in 2023.”

Brady joined euNetworks in March 2009. He has led euNetworks through its delisting on the Singapore Stock Exchange, privatisation with Columbia Capital, and sale to Stonepeak, with increased investment from IMCO. The business has become a critical bandwidth infrastructure company supporting Europe’s future bandwidth needs and a portfolio of customers who are the fastest growing consumers of bandwidth under his leadership. Brady has guided the company to become the leading data centre to data centre connectivity provider in Europe, with a unique set of connectivity options in both its metro and long haul network, including the development of Super Highways and new subsea cables. This has enabled the company to deliver exceptional growth and success, underpinned by a team with collective company values and a focus on the belief that bandwidth changes everything.

“I’m immensely proud of the team and it has been a privilege working with them as well as our investors, customers, partners and with the communities that we operate in across Europe,” said Brady Rafuse. “Paula is an exceptional leader. Her achievements in her career have been underpinned by her ability to foster strong relationships with customers and partners whilst remaining focused on leading organisations and people. Paula joined the euNetworks team a year ago and since then we have been working closely to ensure a smooth transition as we move forward with our plans and continue to grow the business. With Paula’s focus over the last year on all operating aspects of the business and her customer-centric approach, she has already made a great contribution to our performance in 2022 and I am excited for the company’s future with Paula as CEO. Thank you to Neil for his support, contribution and guidance since joining the euNetworks Board of Directors in January 2014. His extensive and global board and management experience has been hugely valuable to us all during his time as Chairman on our Board.”

“We know Paula is a fantastic leader and, like Brady, has a clear vision to guide euNetworks as we progress with growth plans for the business,” said Cyrus Gentry, Managing Director and Head of Communications, Europe at Stonepeak. “euNetworks is the fastest growing fibre business in Europe. It has a highly differentiated network platform that underpins the digital infrastructure ecosystem and there remains no shortage of compelling capital opportunities in Europe for euNetworks to further build on the unique position it has in the region. We extend our thanks to Brady for everything he has delivered as CEO, and we look forward to the value he will continue to deliver as Chairman.”

About euNetworks

euNetworks is a critical bandwidth infrastructure company, owning and operating 17 fibre based metropolitan networks connected with a high capacity intercity backbone covering 53 cities in 17 countries across Europe. The company leads the market in data centre connectivity, directly connecting over 490 today. euNetworks is also a leading cloud connectivity provider and offers a targeted portfolio of metropolitan and long haul services including Dark Fibre, Wavelengths, and Ethernet. Wholesale, finance, content, media, mobile, data centre and enterprise customers benefit from euNetworks’ unique inventory of fibre and duct based assets that are tailored to fulfil their high bandwidth needs. For further information visit eunetworks.com.

About Stonepeak

Stonepeak is a leading alternative investment firm specializing in infrastructure and real assets with approximately $51.7 billion of assets under management. Through its investment in defensive, hard-asset businesses globally, Stonepeak aims to create value for its investors and portfolio companies, and to have a positive impact on the communities in which it operates. Stonepeak sponsors investment vehicles focused on private equity and credit. The firm provides capital, operational support, and committed partnership to sustainably grow investments in its target sectors, which include communications, energy transition, transport and logistics, and social infrastructure. Stonepeak is headquartered in New York with offices in Austin, Hong Kong, Houston, London and Sydney. For more information, please visit www.stonepeak.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221206005159/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye